BioPharma Pharma QC

Elpiscience, Astellas Ink Deal for Novel Bispecific Macrophage Engager

 The two companies will collaboratively conduct early-stage research for these two programs. Elpiscience will also grant Astellas the right to add up ...

 January 01, 2024 | News

NOW tested over thirty Berberine supplements after surveying the online marketplace for questionable products.

Goldenseal is one well-known example of a berberine-rich plant and enjoys a long history of medicinal use by Native American tribes. Berberine has rece...

 December 27, 2023 | News

Astellas Completes Acquisition of Propella Therapeutics

Through the acquisition of Propella, Astellas has acquired PRL-02 (abiraterone decanoate), a next-generation androgen biosynthesis inhibitor being develope...

 December 22, 2023 | News

Dr. Reddy’s First Indian Pharma Firm to Join Dow Jones Sustainability World Index

In a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the ...

 December 15, 2023 | News

WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader

The three-day comprehensive audit covered the CDMO site's drug substance (DS) facility, drug product (DP) facility, QC laboratories, warehouse, and utiliti...

 December 07, 2023 | News

GMP cell CDMO I Peace, Inc. obtains accreditation as ISO 17025: 2017 compliant

Leading GMP cell CDMO I Peace, Inc. , specializing in induced pluripotent stem cells (iPSCs) and iPSC-derived cell therapies, announced that its&...

 December 07, 2023 | News

Daewoong Pharmaceutical Received GMP Certification from Brazilian ANVISA

Daewoong Pharmaceutical, represented by CEO Seng-ho Jeon and Chang-Jae Lee, proudly announced that their Osong factory passed the Brazilian Good Manuf...

 November 28, 2023 | News

Simcere and Connect ink exclusive deal for autoimmune drug Rademikibart.

Pursuant to the Agreement, Simcere obtains the exclusive rights in the development, manufacturing, and commercialization of Rademikibart for all indication...

 November 24, 2023 | News

WuXi Biologics Achieves Breakthrough Productivity of ~6 g/L/day in Integrated Continuous Process at Pilot Scale

  By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...

 November 23, 2023 | News

Merck Debuts ChemisTwin™: Digital Reference Materials Platform

Accelerates digitalization in labs and manufacturing by offering traceable digital records of physical reference materials Allows Pharma QC/QA and R&...

 November 16, 2023 | News

In Conversation with Eugene Kang: Pioneering the Future of Cell Therapy with Thermo Fisher's CTS Detachable Dynabeads

In an exclusive Q&A by BioPharma APAC  with Eugene Kang, Senior Product Manager for Cell Therapy at Thermo Fisher Scientific, we delve into the gr...

 November 15, 2023 | News

Telix, an Australian Company, Announces Planned Acquisition of QSAM Biosciences and its Lead Therapy Candidate, CycloSam

CycloSam® is highly synergistic with Telix's existing therapeutic development activity in both prostate cancer and sarcoma. The proposed acquisiti...

 November 14, 2023 | News

MasterControl's Manufacturing Excellence Surpasses 150 Customers Worldwide

MasterControl, a leading provider of quality management and next generation manufacturing execution software, announced a major milestone with over 150 cus...

 November 13, 2023 | News

Cytiva and RoosterBio collaborate to address exosome manufacturing challenges

  Aiming to improve exosome purification process that is currently slowing adoption of promising gene therapies and other new modalities A scalabl...

 October 30, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in